Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros













Base de datos
Intervalo de año de publicación
1.
J Basic Microbiol ; 61(3): 253-264, 2021 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-33543807

RESUMEN

The heme oxygenase gene has antioxidant and cytoprotective effects in organisms, but no related research has been conducted in Ganoderma lucidum. For the first time, we cloned the HMX1 gene in G. lucidum. The CDS is 1092 bp in length and encodes 363 amino acids. The HMX1 protein was prokaryotically expressed and purified, and the enzyme activity of the purified protein was measured. The value of Km was 0.699 µM, and Vm was 81.9 nmol BV h-1 nmol-1 protein. By constructing the silencing vector pAN7-dual-HMX1i, the transformants HMX1i1 and HMX1i2 were obtained. Compared with the wild-type (WT), the average growth rate of HMX1i1 and HMX1i2 decreased by 31% and 23%, respectively, and the mycelium biomass decreased by 53% and 48%, respectively. Compared with the WT, the extracellular polysaccharide content of HMX1i1 and HMX1i2 increased by 59% and 51%, and the intracellular polysaccharide content increased by 24% and 22%, respectively. These results indicate that the HMX1 gene affects mycelial growth and polysaccharide synthesis in G. lucidum.


Asunto(s)
Antioxidantes/metabolismo , Polisacáridos Fúngicos/antagonistas & inhibidores , Hemo Oxigenasa (Desciclizante)/genética , Reishi/crecimiento & desarrollo , Reishi/genética , Biomasa , Citoprotección/fisiología , Polisacáridos Fúngicos/biosíntesis , Micelio/crecimiento & desarrollo , Interferencia de ARN , ARN Interferente Pequeño/genética
2.
J Microbiol Biotechnol ; 29(8): 1204-1211, 2019 Aug 28.
Artículo en Inglés | MEDLINE | ID: mdl-31336432

RESUMEN

Fungal exopolysaccharides are important natural products having diverse biological functions. In this study, exopolysaccharides from Fomitopsis castanea mycelia (FEPS) were prepared, and the highest mushroom tyrosinase inhibitory activity was found. FEPS were prepared from cultivation broth by ethanol precipitation method. The extraction yield and protein concentration of FEPS were 213.1 mg/l and 0.03%, respectively. FEPS inhibited mushroom tyrosinase with the half maximal inhibitory concentration (IC50) of 16.5 mg/ml and dose-dependently inhibited cellular tyrosinase activity (63.9% at 50 µg/ml, and 83.3% at 100 µg/ml) in the cell-free extract of SK-MEL-5 human melanoma cell and α-melanocytestimulating hormone (α-MSH)-stimulated melanin formation in intact SK-MEL-5 human melanoma cell. The IC50 of FEPS against NO production from RAW264.7 macrophage cells was 42.8 ± 0.64 µg/ml. By in vivo study using a zebrafish model, exposure of FEPS at 400 µg/ml to dechorionated zebrafish embryos for 18 h decreased the pigment density, compared to that without FEPS-treated control.


Asunto(s)
Coriolaceae/metabolismo , Polisacáridos Fúngicos/antagonistas & inhibidores , Polisacáridos Fúngicos/metabolismo , Melanoma/tratamiento farmacológico , Micelio/metabolismo , Agaricales/enzimología , Animales , Línea Celular Tumoral/efectos de los fármacos , Supervivencia Celular/efectos de los fármacos , Modelos Animales de Enfermedad , Polisacáridos Fúngicos/aislamiento & purificación , Humanos , Concentración 50 Inhibidora , Melaninas/metabolismo , Melanocitos/efectos de los fármacos , Melanoma Experimental , Ratones , Monofenol Monooxigenasa/efectos de los fármacos , Células RAW 264.7 , Pez Cebra , alfa-MSH/efectos de los fármacos
3.
Antimicrob Agents Chemother ; 60(4): 2185-94, 2016 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-26810653

RESUMEN

Candida albicansis a leading nosocomial pathogen. Today, candidal biofilms are a significant cause of catheter infections, and such infections are becoming increasingly responsible for the failure of medical-implanted devices.C. albicansforms biofilms in which fungal cells are encased in an autoproduced extracellular polysaccharide matrix. Consequently, the enclosed fungi are protected from antimicrobial agents and host cells, providing a unique niche conducive to robust microbial growth and a harbor for recurring infections. Here we demonstrate that a recently developed platform comprised of nanoparticles that release therapeutic levels of nitric oxide (NO-np) inhibits candidal biofilm formation, destroys the extracellular polysaccharide matrices of mature fungal biofilms, and hinders biofilm development on surface biomaterials such as the lumen of catheters. We found NO-np to decrease both the metabolic activity of biofilms and the cell viability ofC. albicansin vitroandin vivo Furthermore, flow cytometric analysis found NO-np to induce apoptosis in biofilm yeast cellsin vitro Moreover, NO-np behave synergistically when used in combination with established antifungal drug therapies. Here we propose NO-np as a novel treatment modality, especially in combination with standard antifungals, for the prevention and/or remediation of fungal biofilms on central venous catheters and other medical devices.


Asunto(s)
Antifúngicos/farmacología , Biopelículas/efectos de los fármacos , Candida albicans/efectos de los fármacos , Candidiasis/tratamiento farmacológico , Infecciones Relacionadas con Catéteres/tratamiento farmacológico , Óxido Nítrico/farmacología , Animales , Antifúngicos/química , Apoptosis/efectos de los fármacos , Biopelículas/crecimiento & desarrollo , Candida albicans/crecimiento & desarrollo , Candidiasis/microbiología , Infecciones Relacionadas con Catéteres/microbiología , Cateterismo Venoso Central , Quitosano/química , Modelos Animales de Enfermedad , Quimioterapia Combinada , Femenino , Fluconazol/farmacología , Polisacáridos Fúngicos/antagonistas & inhibidores , Polisacáridos Fúngicos/química , Hifa/efectos de los fármacos , Pruebas de Sensibilidad Microbiana , Viabilidad Microbiana/efectos de los fármacos , Nanopartículas/química , Óxido Nítrico/síntesis química , Donantes de Óxido Nítrico/química , Donantes de Óxido Nítrico/farmacología , Compuestos de Organosilicio/química , Oxidación-Reducción , Ratas , Ratas Sprague-Dawley , Nitrito de Sodio/química , Voriconazol/farmacología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA